Many standard treatments for congestive heart failure (e.g. beta blockers, angiotensin converting enzyme [ACE] inhibitors, angiotensin receptor blocker [ARBs], and angiotensin receptor neprilysin inhibitors [ARNIs]) are either contraindicated or poorly tolerated at high doses in patients with AL amyloidosis. The gene discussed is ACE; the disease is congestive heart failure.